OATD-02

N/A

Report date: 2024/10/18 17:38:05
NME

Base Information

Drug NameOATD-02
Drug Alias NameOATD-02OAT-1746EX-A8043HY-155108
ClassificationSmall molecules
Mechanisms of ActionArginase-1 inhibitorsArginase 2 inhibitors
TargetsArginase-1Arginase 2
Therapy Area/IndicationsOvarian NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOncoArendi Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMolecure SA
Inactive CompaniesOncoArendi Therapeutics Inc
Active IndicationsOvarian NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[4
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A